Montgomery & Ponder, LLC attorneys are investigating potential lawsuits on behalf of people who have had a leg, foot or toe amputation while taking Invokana.
The FDA recently issued a Black Box Warning for users of diabetes medication, Invokana. The Black Box Warning states that Invokana has been shown to increase the risk of leg, foot and toe amputations. Clinical trials discovered that amputations occur approximately twice as often in patients taking the drug as compared with those who took a placebo. The FDA’s information release also recommends that health care practitioners consider other patient information which may add to the increased risk before prescribing Invokana. It states that conditions such as neuropathy, peripheral vascular disease, foot ulcers and prior history of amputation may predispose patients to a need for amputation. Patients should be closely monitored and Invokana discontinued if complications develop.
In addition to lawsuits related to amputations injuries, there have been numerous lawsuits against the makers of Invokana that allege health issues arising after taking the drug such as kidney failure, ketoacidosis, as well as strokes, heart attacks.
Patients are encouraged to report development of symptoms such as new pain or tenderness, sores, ulcers, or infections. They should not stop taking Invokana but should contact their health care practitioner.
If you or someone you love has suffered an amputation, ketoacidosis, heart problems, kidney problems, or any other serious health condition while taking Invokana, you may be entitled to compensation. For a free consultation, please contact Montgomery Ponder immediately by (205) 377-5004.